Search Results 2611-2620 of 25337 for oral
Patients with active, moderate-high disease activity RA (CDAI ≥ 10 and HAQ ≥ 0.5) despite the use of MTX ≥ 3 months with a stable dose ≥ 15 mg/week (oral or ...
Treatment with >1 IV dose of cyclophosphamide and/or >14 days of oral cyclophosphamide and/or >14 days of prednisone/prednisolone (>30 mg/day) and/or >1 ...
... (oral, intravaginal, transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...
ExaminerMusculoskeletal Oral Boards, American Board of Radiology. 2012. DirectorOrthopedic Practice Society Annual Meeting. 2010 - present. Committee Member ...
Oral and Maxillofacial Surgeon; Surgeon. Rochester, MN. Areas of focus: Cancer rehabilitation, Cancer treatment, Skin biopsy, Trauma care, Sentinel node biopsy ...
Myocardial ischemia reduces blood flow to the heart and may cause chest pain – but not always. Learn all the signs and symptoms and how to treat it.
The purpose of this study is to demonstrate feasibility of conducting a decentralized therapeutic clinical trial of triple oral metronomic therapy using ...
... oral contraceptives are not allowed on study; postmenopausal is defined as: Age >= 60 years; Age =< 60 years and amenorrheic for 12 months in the absence of ...
... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Oropharyngeal cancer, Radiation injury, Hypopharyngeal cancer. Show more areas of focus for ...
Per-Oral Endoscopic Myotomy (POEM); Gastric Per-Oral Endoscopic Myotomy (GPOEM); Resection of GI precancer/early cancer with endoscopic mucosal resection (EMR) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.